The future of everyday healthcare is in our hands

The Re/Wire Health Studio from GSK NEXT is on a mission to democratise access to everyday healthcare, create seamless health experiences, and improve health outcomes for consumers.

GSK’s world-leading Consumer Healthcare business combines science and consumer insights to create innovative everyday healthcare brands that consumers trust and experts recommend for oral health, pain relief, cold, flu and allergy, digestive health and vitamins, minerals and supplements.

GSK NEXT will partner with participating startups to offer mentorship, R&D support, and commercialisation opportunities. The GSK NEXT team will work directly with startups, and will help them navigate the resources of GSK at large.

R/GA Ventures will act as an operational partner in the Studio, contributing to the overall innovation strategy, startup selection, and nine-week Studio execution. R/GA’s award-winning strategists, technologists, creatives, and consultants will advise the six startups selected for the Studio and prepare them for future milestones. Startups will have exposure and access to R/GA’s global client network and industry-spanning corporate partners. R/GA’s creative talent will develop pitch materials and be available to consult on startups’ presentations ahead of the demo event at the end of the program.

Yes, applications for the first cohort open on August 9, 2021 and close September 20, 2021.

The Re/Wire Health Studio is built to collaborate with startups building next generation solutions that can address evolving consumer needs. Each focus area is aligned with core ideas surrounding everyday health issues, including proactive care. Learn more about the three focus areas of opportunity above.

1. Strategic partnership opportunities – working in depth with GSK in order to facilitate opportunities for rapid global scale.
2. Mentoring and networking – the studio is pulling together a panel of leaders, innovators, investors and entrepreneurs in the Consumer Health space
3. Potential cash grant – Select members of the Studio cohort will receive a one-time cash grant of £30k.

The Studio will identify strategic opportunities for startups to partner with GSK and provide the selected Studio companies with the market opportunities, guidance, and partnerships to build momentum towards scaling globally. Selected startups will have access to R/GA’s creative capital services with award-winning strategists, technologists, creatives, and consultants to help them develop their businesses and prepare them for future milestones.

The Studio invites applications from innovative growth- and early-stage companies with disruptive technologies that will shape the future of consumer health. The Studio welcomes applications from startups with pre-seed through Series A funding.

GSK NEXT welcomes startups from around the world to apply, but must be capable and prepared to launch in the U.S. with a minimum viable product or service in development or in-market.

Investment is not a component of the Studio; however, GSK NEXT may seek to invest in participating startups after the conclusion of the program. Participation in the program is not contingent upon the possibility of future investment, and GSK NEXT will not seek the right to invest as part of the program.

All Studio participation and programming will be done virtually. Founders are not required to relocate themselves or their team to participate.

No, there is no fee or equity charge to apply or participate in the Re/Wire Health Studio.

The application period for the first cohort of the Re/Wire Health Studio is from August 9 through September 20, 2021. Top prospects will be invited to participate in a virtual pitch session to a selection panel of GSK stakeholders between Oct 4 – 8, 2021.

Finalists will be selected based on quality of product or service (or path to product or service), robustness of business model, strength of team, and alignment with GSK NEXT’s objectives. Selected companies will go through a technical and business due diligence process.

Participation in other accelerator programs will not exclude startups from the Re/Wire Health Studio, but preference will be given to companies that can devote the time required to pursue the full range of opportunities delivered by the Studio. Startups that have active or past partnerships or commercial engagement with competitors of GSK may not be eligible to participate.

GSK is a science-led global healthcare company with a special purpose: to help people do more, feel better, and live longer. For further information please visit https://us.gsk.com/en-us/about-us/.

GSK NEXT is the strategic commercial growth engine for GSK Consumer Healthcare, focused on the creation and scaling of net-new product, service and platform businesses across everyday health.

R/GA designs businesses and brands for a more human future. A leader in technology and creativity for more than 40 years, R/GA has expanded and evolved its capabilities in anticipation of technology’s impact on its clients’ businesses to offer services through our award-winning consulting, Ventures, technology, design, communications, and IP practices.

R/GA Ventures helps corporate leaders identify and capitalise on disruptive technologies and emerging behaviors while supporting startups with financial and creative capital to drive growth and returns. Our expertise in the startup ecosystem, coupled with our experience transforming Enterprise businesses, allows us to identify, develop, and test solutions to close the corporate innovation gap. We exist to test new products, services, and business models to fuel new waves of growth for our clients.